Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Advanced Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06783569
What this trial is testing

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsGastric CancerEsophagogastric Juction Cancer+1 more
JiaRay Group 94
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Study completedNCT02052778
What this trial is testing

TAS-120 in Patients With Advanced Solid Tumors

Who this might be right for
CholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more
Taiho Oncology, Inc. 407
Large-scale testing (Phase 3)Ended earlyNCT00812240
What this trial is testing

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 335
Testing effectiveness (Phase 2)Ended earlyNCT01994213
What this trial is testing

Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd. 53
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Study completedNCT02359058
What this trial is testing

Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer

Who this might be right for
Stomach Neoplasms
Eli Lilly and Company 18
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Not applicableStudy completedNCT03629691
What this trial is testing

Study for Patients With Lung Metastatic Advanced Gastric Cancer and NSCLC Treated With Apatinib

Who this might be right for
Gastric Cancer Metastatic to LungLung Cancer
The Affiliated Hospital of Qingdao University 187
Early research (Phase 1)Looking for participantsNCT05262491
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Who this might be right for
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 96
Very early researchLooking for participantsNCT06937567
What this trial is testing

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Who this might be right for
Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University 36
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Testing effectiveness (Phase 2)Study completedNCT01525771
What this trial is testing

Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer

Who this might be right for
Stage IV Gastric Cancer With Metastasis
Asan Medical Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07102901
What this trial is testing

Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

Who this might be right for
Advanced Gastric CancerMetastatic Gastric CancerGastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd. 351
Testing effectiveness (Phase 2)Ended earlyNCT05091528
What this trial is testing

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more
Silverback Therapeutics 2
Early research (Phase 1)UnknownNCT03847168
What this trial is testing

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer

Who this might be right for
Breast CancerGastric/Gastroesophageal Junction Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 22
Not applicableUnknownNCT04886193
What this trial is testing

FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis

Who this might be right for
ChemotherapyGastric Cancer
Guangdong Provincial Hospital of Traditional Chinese Medicine 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03653507
What this trial is testing

Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Next Page
507